USFDA conducts audit of Stride Alathur's formulations unit

Strides Pharma Science announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility of Strides Alathur, a wholly owned subsidiary of the Company, at Alathur, Chennai during the week of 01 April 2024 to 05 April 2024. The inspection closed with two observations.

Powered by Capital Market - Live News